Explore By Subject Area   
Return Home
Menu

Lead Editorial

How Memorial Sloan Kettering Cancer Center Scaled EHR-to-EDC Technology

How Memorial Sloan Kettering Cancer Center Scaled EHR-to-EDC Technology

Memorial Sloan Kettering (MSK) Cancer Center’s Senior Director of Clinical Research Informatics and Technology, Joe Lengfellner, tells us how MSK validated and scaled EHR-to-EDC technology across MSK’s vast portfolio of trials.

Read More

Featured Editorial

How Merck Research Labs Is Evolving its Global Clinical Supply to Meet the Demands of Newer Modalities

Read More

Biogen on Digital Innovations to Increase Trial Access and Enhance Patient Experiences

Read More

What Clinical Research Means to Patients in Ukraine, and How Industry Sponsors Can Help

Read More

How CMOs can Leverage AI to Streamline Clinical Development

Read More

How the Roche RNAHub is Advancing Oligonucleotide Development and Delivery

Read More

Editorial by Category

Modernizing Clinical Trial Operations

View All
The Small Pharma Approach to Innovation, with Kyowa Kirin’s SVP of Global Clinical Operations
The Small Pharma Approach to Innovation, with Kyowa Kirin’s SVP of Global Clinical Operations
Driving Patient-Centered Trials with Outcome Measures
Driving Patient-Centered Trials with Outcome Measures
Empathy: The Strategic Edge in the AI Era with Fred Hassan
Empathy: The Strategic Edge in the AI Era with Fred Hassan
How Power, DPHARM Idol 2024, Is Building the AI Platform for Central Patient Recruitment
How Power, DPHARM Idol 2024, Is Building the AI Platform for Central Patient Recruitment

Immuno-Oncology and Cell Therapy

View All
Whole-Body Molecular Imaging’s Impact on Understanding Tumor Response and Advancing Immuno-Oncology (IO) Drug Development
Whole-Body Molecular Imaging’s Impact on Understanding Tumor Response and Advancing Immuno-Oncology (IO) Drug Development
Going After Immune Resistance and Metastases in Cancer Using RNA-Based Therapeutics
Going After Immune Resistance and Metastases in Cancer Using RNA-Based Therapeutics
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
GSK’s Head of Precision Medicine on Biomarker Focus and the Use of Next-Generation Technologies
GSK’s Head of Precision Medicine on Biomarker Focus and the Use of Next-Generation Technologies

Drug Delivery

View All
Empathy: The Strategic Edge in the AI Era with Fred Hassan
Empathy: The Strategic Edge in the AI Era with Fred Hassan
Micronization and Milling: A Strategic Tool to Enhance Drug Development and Manufacturing
Micronization and Milling: A Strategic Tool to Enhance Drug Development and Manufacturing
De-risking Combination Product Development Through Early Data-Driven Evaluation of Container Closure Systems
De-risking Combination Product Development Through Early Data-Driven Evaluation of Container Closure Systems
Leading Drug Delivery Conference PODD Announces its 15th Annual Agenda
Leading Drug Delivery Conference PODD Announces its 15th Annual Agenda

Patients as Partners in Clinical Research and Patient Access

View All
Collaborating for Change: Integrating Clinical Trials into Care Pathways
Collaborating for Change: Integrating Clinical Trials into Care Pathways
Operationalizing a New R&D Patient-Centricity Model at J&J
Operationalizing a New R&D Patient-Centricity Model at J&J
Involving Patient Insights in Medicine Development to Better Support Access and Decision-Making: Patients as Partners Europe 2025 Recap
Involving Patient Insights in Medicine Development to Better Support Access and Decision-Making: Patients as Partners Europe 2025 Recap
How Pfizer Is Tackling Patient Insight Continuity Across a Global Organization
How Pfizer Is Tackling Patient Insight Continuity Across a Global Organization

Biotech CMO/R&D Leadership

View All
Empathy: The Strategic Edge in the AI Era with Fred Hassan
Empathy: The Strategic Edge in the AI Era with Fred Hassan
Commercializing Therapies Requires Patient-Centricity and Advocacy
Commercializing Therapies Requires Patient-Centricity and Advocacy
How Investors Evaluate Biotech Companies and CMOs
How Investors Evaluate Biotech Companies and CMOs
One CMO’s Career Journey to Becoming CEO
One CMO’s Career Journey to Becoming CEO

CRAACO: Clinical Research as a Care Option

View All
Insights: Six Actions for Academic Health Systems to Achieve a High-Performing Clinical Trials Program
Insights: Six Actions for Academic Health Systems to Achieve a High-Performing Clinical Trials Program
How Dana-Farber Makes Clinical Trials Fit-For-Purpose in the Community Clinic Setting
How Dana-Farber Makes Clinical Trials Fit-For-Purpose in the Community Clinic Setting
How to Use Patient-Reported Outcomes to Bring Better Drugs Forward for Patients
How to Use Patient-Reported Outcomes to Bring Better Drugs Forward for Patients
Expanding Access and Accelerating Cancer Drug Development through Community-Based Oncology Research
Expanding Access and Accelerating Cancer Drug Development through Community-Based Oncology Research

Women Leadership in Biotech

View All
The Conference Forum Sees Record Growth in Attendees Across 2024 Events, Bringing Together Leaders in Medicine Development
The Conference Forum Sees Record Growth in Attendees Across 2024 Events, Bringing Together Leaders in Medicine Development
Women Leadership in Immuno-Oncology: 2022 Celebration Series
Women Leadership in Immuno-Oncology: 2022 Celebration Series
Women Leadership in Immuno-Oncology: 2021 Celebration Series
Women Leadership in Immuno-Oncology: 2021 Celebration Series
Women Leadership in Immuno-Oncology: 2020 Celebration Series
Women Leadership in Immuno-Oncology: 2020 Celebration Series

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.